Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/40233
Title: A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease
Authors: Dagorn, Pascale Gluais
Buchholz, Bjoern
Kraus, Andre
Batchuluun, Battsetseg
Bange, Hester
BLOCKKEN, Laura 
Steinberg, Gregory R.
Moller, David E.
Hallakou-Bozec, Sophie
Issue Date: 2023
Publisher: ELSEVIER SCIENCE INC
Source: KIDNEY INTERNATIONAL, 103 (5) , p. 917 -929
Abstract: A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease
Notes: Hallakou-Bozec, S (corresponding author), Poxel SA, 259 Av Jean Jaures, F-69007 Lyon, France.
sophie.bozec@poxelpharma.com
Keywords: ADPKD;AMPK;PXL770;fibrosis;inflammation;mitochondria;Mice;Animals;Dogs;Adenosine Monophosphate;AMP-Activated Protein Kinases;Kidney;Mice, Knockout;Disease Progression;TRPP Cation Channels;Polycystic Kidney, Autosomal Dominant;Renal Insufficiency;Cysts
Document URI: http://hdl.handle.net/1942/40233
ISSN: 0085-2538
e-ISSN: 1523-1755
DOI: 10.1016/j.kint.2023.01.026
ISI #: 000984794600001
Rights: 2023, International Society of Nephrology. Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.